...
首页> 外文期刊>International journal of clinical pharmacy. >Drug utilization evaluation of albumin in a teaching hospital of Mashhad, Iran: an interventional pre-post design study
【24h】

Drug utilization evaluation of albumin in a teaching hospital of Mashhad, Iran: an interventional pre-post design study

机译:伊朗Mashhad教学医院中白蛋白药物利用评价:介入前的设计前设计研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Albumin is a protein colloidal solution with limited availability and high cost. It should be used in such approved indications as paracentesis, extensive burn, spontaneous bacterial peritonitis, and nephrotic syndrome. Objectives The aim of this study was to evaluate and compare the appropriateness of albumin usage before and after an evidence-based guideline. Setting Four wards of Imam Reza Hospital, Mashhad, Iran. Method An interventional pre-post design study was performed on 2 groups of patients; in gGroup 1 as a preparation phase group in 6 months from February 2015 to July 2015 and Group 2 as an interventional group from September 2015 to February 2016. A guideline for proper indications of albumin, designed and finalized based on the physicians' comments, was implemented in Group 2. Main outcome measure The pattern of albumin consumption. Results Fifty patients were evaluated in each group. The implementation of the guideline resulted in reduction of improper albumin use from 62 to 57.5%, which was not statistically significant; however., it reduced inappropriate dose and duration of albumin therapy (55.5-16.7%), the number of consumed albumin vial, and the average cost for each patient (317.78 +/- 3.15-149.81 +/- 1.91 USD) significantly, as well. Conclusion This study illustrated that in this hospital in most cases, albumin was used inappropriately and at an alarming rate. This improved after the introduction of an evidence-based guideline. Moreover, guideline implementation resulted in significant cost reduction.
机译:背景白蛋白是一种蛋白质胶体溶液,可用性有限和高成本。它应该在这种经批准的指示中使用,作为腹腔气囊,广泛的烧伤,自发性细菌性腹膜炎和肾病综合征。目的本研究的目的是评估和比较基于证据的指南之前和之后白蛋白使用的适当性。设置伊朗马什哈德的伊玛雷扎医院四个病房。方法对2组患者进行介入后设计研究;在GGroup 1作为2015年2月至2015年2月的6个月内的准备阶段组,第2次作为介入集团于2015年9月至2016年2月。基于医生评论的白蛋白,设计和最终确定的适当指示的指导性是在第2组中实施。主要结果测量白蛋白消费的模式。结果在每组中评估50名患者。该指南的实施导致从62%到57.5%的不正确的白蛋白使用,这在统计学上没有统计学意义;然而。,它减少了不恰当的剂量和白蛋白疗法持续时间(55.5-16.7%),消耗的白蛋白小瓶的数量,以及每位患者的平均成本(317.78 +/- 3.15-149.81 +/- 1.91 USD)显着,如此好。结论本研究表明,在大多数情况下,在本医院中,白蛋白被不恰当地使用并且以惊人的速度使用。在引入基于证据的指南后,这种改进了。此外,指南实施导致成本大幅减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号